phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|
phs000547.v1.p1 A Genome-Wide Association Study in Breast Cancer Patients from the SUCCESS Trial | Version 1: passed embargo
| VDAS | 3596 | Prospective, Randomized, Phase III | Links | HumanOmniExpress-FFPE BeadChip
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000092.v1.p1 Study of Addiction: Genetics and Environment (SAGE) | Version 1: passed embargo
| VDAS | 4121 | Case-Control | Links | ILMN_Human-1
|
phs001405.v1.p1 Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 | Version 1: passed embargo
| VDAS | 12 | Clinical Trial | Links | HiSeq 2000
|
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000391.v1.p1 Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study | Version 1: passed embargo
| VDAS | 666 | Interventional | Links | Mapping250K_Nsp Mapping250K_Sty AFFY_6.0
|
phs000305.v1.p1 PGRN-RIKEN NSABP Prevention Study | Version 1: passed embargo
| VDAS | 1763 | Nested Case-Control | Links | Human610_Quadv1_B
|
phs000210.v1.p1 PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study | Version 1: passed embargo
| VDAS | 879 | Nested Case-Control | Links | |
phs000813.v1.p1 Sequencing of Targeted Genomic Regions Associated with Smoking | Version 1: passed embargo
| VDAS | 2969 | Case-Control | Links | HumanExome BeadChip v1.1 HiSeq 2000
|
phs000606.v1.p1 HIT after Cardiac Bypass | Version 1: passed embargo
| VDAS | 1051 | Longitudinal, Prospective, Population, Sequencing | Links | |
phs000575.v1.p1 PWS Natural History Protocol | Version 1: passed embargo
| VDAS | 200 | Case Set | | |
phs000378.v1.p1 Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia | Version 1: passed embargo
| VDAS | 1251 | Community, Longitudinal, Cross-Sectional | Links | HumanOmni2.5
|
phs000126.v2.p1 CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) | Versions 1-2: passed embargo
| VDAS | 1991 | Case-Control | Links | HumanCNV370v1
|
phs000048.v1.p1 Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration | Version 1: passed embargo
| VDAS | 1550 | Case-Control | Links | PERLEGEN-85K
|